Production Assistance for Cellular Therapies (PACT)- Cell Processing Facilities Cell manufacturing and process development services for RSA PCT0035-01: Preclinical Development of PB-derived iTregs

细胞疗法生产协助 (PACT) - 细胞加工设施 RSA 的细胞制造和工艺开发服务 PCT0035-01：PB 衍生 iTreg 的临床前开发

• 批准号: 10115183
• 负责人: DAVID MCKENNA
• 金额: $ 56.15万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-11-01 至 2020-10-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10115183
• 关键词: Cell Therapy; Cells; Hematopoietic; Methods; Modification; Multicenter Trials; Prevention trial; Production; STAT3 gene; Services; Transplantation; inhibitor/antagonist; manufacturing process development; peripheral blood; preclinical development

The objective of this project is to develop an optimized approach to isolation and expansion of peripheral blood-derived iTregs.

本项目的目标是开发一种分离和扩增外周血来源的iTregs的优化方法。